These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25368027)

  • 1. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
    Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension.
    Jackson EK; Mi Z
    Hypertension; 2008 Jun; 51(6):1637-42. PubMed ID: 18443229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
    Tofovic DS; Bilan VP; Jackson EK
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):689-91. PubMed ID: 20374254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
    Jackson EK; Kochanek SJ; Gillespie DG
    Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    Giannocco G; Oliveira KC; Crajoinas RO; Venturini G; Salles TA; Fonseca-Alaniz MH; Maciel RM; Girardi AC
    Eur J Pharmacol; 2013 Jan; 698(1-3):74-86. PubMed ID: 23051671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm.
    Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25158865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.
    Liu L; Liu J; Tian XY; Wong WT; Lau CW; Xu A; Xu G; Ng CF; Yao X; Gao Y; Huang Y
    Antioxid Redox Signal; 2014 Oct; 21(11):1571-81. PubMed ID: 24328731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
    Hausenloy DJ; Whittington HJ; Wynne AM; Begum SS; Theodorou L; Riksen N; Mocanu MM; Yellon DM
    Cardiovasc Diabetol; 2013 Oct; 12():154. PubMed ID: 24148218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Dipeptidyl Peptidase 4 Inhibition Worsens Hypertension and Renal and Cardiac Abnormalities in Obese Spontaneously Hypertensive Heart Failure Rats.
    Jackson EK; Mi Z; Gillespie DG; Cheng D; Tofovic SP
    J Am Heart Assoc; 2021 Mar; 10(6):e020088. PubMed ID: 33682436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dipeptidyl peptidase-4 inhibitor-sitagliptin modulates calcium dysregulation, inflammation, and PPARs in hypertensive cardiomyocytes.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsu MI; Chen YJ
    Int J Cardiol; 2013 Oct; 168(6):5390-5. PubMed ID: 24012160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.
    Jackson EK; Mi E; Ritov VB; Gillespie DG
    Hypertension; 2018 Oct; 72(4):909-917. PubMed ID: 30354710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor.
    Abd El Motteleb DM; Elshazly SM
    Eur J Pharmacol; 2013 Nov; 720(1-3):158-65. PubMed ID: 24238127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory Activity.
    Wang Y; Landheer S; van Gilst WH; van Amerongen A; Hammes HP; Henning RH; Deelman LE; Buikema H
    PLoS One; 2012; 7(10):e46781. PubMed ID: 23071636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats.
    Pacheco BP; Crajoinas RO; Couto GK; Davel AP; Lessa LM; Rossoni LV; Girardi AC
    J Hypertens; 2011 Mar; 29(3):520-8. PubMed ID: 21150640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans.
    Marney A; Kunchakarra S; Byrne L; Brown NJ
    Hypertension; 2010 Oct; 56(4):728-33. PubMed ID: 20679179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
    Esposito G; Cappetta D; Russo R; Rivellino A; Ciuffreda LP; Roviezzo F; Piegari E; Berrino L; Rossi F; De Angelis A; Urbanek K
    Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats.
    Jackson EK; Zhang M; Liu W; Mi Z
    J Pharmacol Exp Ther; 2007 Nov; 323(2):431-7. PubMed ID: 17726157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.